908 Devices (MASS) to Release Quarterly Earnings on Wednesday

05 May 2026, 13:50 by Doug Wharley · The Cerbat Gem

908 Devices (NASDAQ:MASS – Get Free Report) will likely be issuing its Q1 2026 results before the market opens on Wednesday, May 6th. Analysts expect the company to announce earnings of ($0.15) per share and revenue of $13.1620 million for the quarter. Parties can find conference call details on the company’s upcoming Q1 2026 earning report page for the latest details on the call scheduled for Wednesday, May 6, 2026 at 8:30 AM ET.

908 Devices (NASDAQ:MASS – Get Free Report) last issued its quarterly earnings data on Tuesday, March 3rd. The company reported ($0.05) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.01. 908 Devices had a negative return on equity of 14.99% and a net margin of 34.68%.The company had revenue of $17.38 million during the quarter, compared to analysts’ expectations of $16.19 million. On average, analysts expect 908 Devices to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

908 Devices Stock Performance

NASDAQ MASS traded up $0.11 on Tuesday, reaching $6.66. The stock had a trading volume of 159,100 shares, compared to its average volume of 293,184. 908 Devices has a 12-month low of $4.20 and a 12-month high of $9.34. The business’s 50-day moving average price is $6.60 and its 200 day moving average price is $6.51. The stock has a market cap of $249.23 million, a P/E ratio of 12.10 and a beta of 0.57.

Insider Transactions at 908 Devices

In other 908 Devices news, SVP John Kenneweg sold 7,787 shares of 908 Devices stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of $6.83, for a total value of $53,185.21. Following the completion of the sale, the senior vice president directly owned 76,039 shares of the company’s stock, valued at approximately $519,346.37. The trade was a 9.29% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Christopher D. Brown sold 17,578 shares of 908 Devices stock in a transaction that occurred on Friday, April 10th. The stock was sold at an average price of $7.07, for a total transaction of $124,276.46. Following the completion of the sale, the director directly owned 945,559 shares of the company’s stock, valued at $6,685,102.13. The trade was a 1.83% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 74,480 shares of company stock valued at $523,432 in the last ninety days. Corporate insiders own 23.70% of the company’s stock.

Institutional Trading of 908 Devices

Institutional investors have recently made changes to their positions in the stock. Wells Fargo & Company MN grew its stake in shares of 908 Devices by 72.1% during the 4th quarter. Wells Fargo & Company MN now owns 30,623 shares of the company’s stock valued at $161,000 after buying an additional 12,828 shares during the period. Cresset Asset Management LLC grew its holdings in shares of 908 Devices by 37.1% during the 3rd quarter. Cresset Asset Management LLC now owns 16,100 shares of the company’s stock worth $141,000 after purchasing an additional 4,355 shares during the period. Engineers Gate Manager LP purchased a new stake in shares of 908 Devices during the 4th quarter worth about $140,000. Graham Capital Management L.P. boosted its position in 908 Devices by 12.9% during the 4th quarter. Graham Capital Management L.P. now owns 20,787 shares of the company’s stock worth $109,000 after purchasing an additional 2,374 shares during the period. Finally, Brevan Howard Capital Management LP purchased a new stake in 908 Devices during the 3rd quarter worth $102,000. 88.06% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

MASS has been the subject of a number of research reports. Wall Street Zen upgraded 908 Devices from a “hold” rating to a “buy” rating in a research note on Saturday, March 14th. Weiss Ratings upgraded 908 Devices from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, April 13th. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $12.00.

Get Our Latest Stock Analysis on MASS

About 908 Devices

(Get Free Report)

908 Devices Inc (NASDAQ: MASS) is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company’s core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.